The International Society for Stem Cell Research releases new guidelines. Regulation needed as new study reveals clinics exaggerate claims and omit risks. – The International Society for Stem Cell Research (ISSCR), the world’s leading professional organization of stem cell researchers, released new guidelines for the responsible development of safe and effective stem cell therapies for patients.
The researchers replaced the left main bronchus of a 30-year-old woman with a specially prepared cadaveric trachea and successfully avoided left pneumonectomy. – The first operation for transplantation of a tissue-engineered airway has been successful. This procedure has massively improved the quality of life of the 30-year-old Colombian female recipient who needed the transplant after contracting tuberculosis.
Millions of people infected with HIV may hope for healing promises, as a patient who has had undetectable HIV viral loads for almost two years after bone marrow transplant. – An HIV-positive person, who underwent a bone marrow transplant to treat leukemia, has had undetectable HIV viral loads for almost two years. HIV-positive man was ill from leukemia and had underwent treatment by the team led by Prof. Eckhard Thiel, director of the Medical Clinic with a focus on hematology and oncology.
Breast stem cell fate is regulated by notch. Errant expression leads to uncontrolled breast ductal cell growth. – A normal developmental protein that sometimes goes awry has been implicated in breast cancer. This discovery indicates the mechanism by which inappropriate expression of the Notch pathway may contribute to breast cancer.
A promising new chemotherapy target for a deadly form of leukemia has been discovered by researchers at the Stanford University Medical Center, US. – Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel “double agent” role for a molecular signal that regulates cell growth.
Biotechnology Industry Organization (BIO) welcomes advances in stem cell research, and stresses continued importance of pursuing all promising areas of research. – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the news that researchers at the Harvard Stem Cell Institute created 20 disease-specific stem cell lines thru the new induced pluripotent stem cell (iPS) technique:
An Australian man who was paralysed by a rugby injury has reportedly made dramatic steps towards recovery after receiving injections of embryonic stem cells from an Indian doctor Geeta Shroff in New Delhi. – An amazing recovery noticed in an Australian Perry Cross who is quadriplegic, after regular injections of embryonic stem cells. Perry Cross was a rugby player and he got the paralysis of all his limbs in 1994 when he was 19 years old. Since then he was on ventilator to breath.
Researchers have succeeded in growing large numbers of stem cells from adult human hearts into new heart muscle cells. – Dutch researchers at University Medical Center Utrecht and the Hubrecht Institute have succeeded in growing large numbers of stem cells from adult human hearts into new heart muscle cells. A breakthrough in stem cell research.
There may be a way to directly create cancer stem cells in the lab so you don?t always have to purify these rare cells from patients in order to study them directly. – With a bit of genetic trickery, researchers at the Stanford University School of Medicine have turned normal skin cells into cancer stem cells, a step that will make these naturally rare cells easier to study.
Researchers showed that therapeutic cloning or SCNT has been successfully used to treat disease in the same subjects from whom the initial cells were derived. – Research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson’s disease in mice.
The Parkinson?s Disease Society (PD) has announced funding of ?170k to the University of Bristol for research into how to make stem cells produce dopamine and live longer after they have been transplanted into animals. – The Parkinson’s Disease Society (PD) has announced funding of ?170k to the University of Bristol for research into how to make stem cells produce dopamine and live longer after they have been transplanted into animals.
Researchers are hoping to develop the first treatment for broken bones using a patient’s own stem cells. – Scientists are developing a revolutionary way to mend damaged bones and cartilage using a patient’s own stem cells.
